![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 Egis Pharmaceuticals PLC (2)
02 Bahrain Pharma (1)
03 Genchain Biotech (1)
04 Hanlim Pharmaceutical (1)
05 Kolmar Korea Co., Ltd. (1)
06 Novell Pharmaceutical Laboratories (1)
07 Opes Health Care (1)
08 Solfran Laboratories (1)
09 Solitaire Pharmacia (1)
10 Vaishali Pharma Ltd (1)
01 Ranitidine Hydrochloride; Bismuth; Sucralfate (1)
02 Sucralfate (9)
03 Sucralfate; Oxethazaine (1)
01 Gel (1)
02 Ointment (1)
03 SUSPENSION (2)
04 Suppository (1)
05 Suspension (3)
06 Tablet (3)
01 1 GM ; 20 MG (1)
02 1000mg (1)
03 1G (1)
04 1G/5ML (3)
05 1GM (1)
06 2.5GM (1)
07 25GM (1)
08 500mg/5ml (1)
09 84MG; 100MG; 300MG (1)
01 Bahrain (1)
02 China (1)
03 Hungary (2)
04 India (3)
05 Indonesia (1)
06 Mexico (1)
07 South Korea (2)